# Observational Study of Apremilast in Patients With Psoriasis in The Netherlands

> **NCT02652494** · — · COMPLETED · sponsor: **Amgen** · enrollment: 154 (actual)

## Conditions studied

- Psoriasis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02652494
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-22
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-06-30
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2024-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02652494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02652494, "Observational Study of Apremilast in Patients With Psoriasis in The Netherlands". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02652494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*